Insulin syringe, fixed-needle
Australia TGA ARTG Registered Device · Livingstone International Pty Ltd · Jiangsu Micsafe Medical Technology Co Ltd · Class IIa · Started December 21, 2023
Good Name: Livingstone International Pty Ltd - Insulin syringe, fixed-needle
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- December 21, 2023
- Effective Date
- December 21, 2023
- Country
- China
- Address
- Xituan Industrial Park Dafeng District, Yancheng, Jiangsu, 224125
The syringe for insulin is intended to inject insulin for the patient.
Access comprehensive regulatory information for Insulin syringe, fixed-needle in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Livingstone International Pty Ltd, manufactured by Jiangsu Micsafe Medical Technology Co Ltd in China. The device registration started on December 21, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.